FDA approves Dublin company's cancer imaging drug

Thursday

Mar 14, 2013 at 12:01 AMMar 14, 2013 at 10:36 AM

The Food and Drug Administration has approved an imaging drug to help doctors locate lymph nodes in patients with breast cancer and skin cancer. The drug Lymphoseek, from Dublin, Ohio-based Navidea Biopharmaceuticals, is a radioactive imaging agent that is intended to help determine if breast cancer or melanoma has spread to a patient's lymph nodes.

The Columbus Dispatch

The Food and Drug Administration has approved an imaging drug to help doctors locate lymph nodes in patients with breast cancer and skin cancer.

The drug Lymphoseek, from Dublin, Ohio-based Navidea Biopharmaceuticals, is a radioactive imaging agent that is intended to help determine if breast cancer or melanoma has spread to a patientís lymph nodes.

Lymphoseek is the first new drug approved to help locate lymph nodes in more than 30 years, according to the FDA.